GDP data will likely ignite another recession debate, while markets sift through a puzzling Fed rate hike and brace for crucial June quarter earnings from Apple after the close of trading.

Stock futures lower with earnings, GDP data in focus; Meta shares tumble after Q2 earnings miss, muted ad outlook; Spirit soars after cancelling frontier deal, setting up JetBlue takeover; Ford shares leap after solid Q2 earnings, outlook hold and Apple earnings on deck amid demand, chip, China impact questions.

It has one product on the market and up to four more launching by the end of 2023. The growth trajectory depends on execution.

Hints of a rate hike pause, buried deep in yesterday's Fed minutes, lift U.S. stocks to a fourth consecutive session of modest gains.

Merck is reportedly eying cancer drug specialists Seagen as it looks to replace revenue from its Keytruda blockbuster, which loses patent exclusivity in 2028.

Stock futures nudge higher after Fed minutes; Samsung posts strongest quarterly profit in four years; Seagen shares jump on report of $40 billion takeover by Merck; GameStop share surge after 4-for-1 stock split plans and Boris Johnson to resign, but seek to stay on as prime minister until autumn.

Wells Fargo put together a "recession portfolio" of stocks for this period of economic weakness.

'A hard landing [for the economy] has become our base case,' as indicated by the two-year Treasury yield, Wells Fargo says.

An emerging therapeutic area continues to draw interest from large drugmakers.

Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO.

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

Well-known for his dislike of covid mandates, Elon Musk did not shy away from using the pandemic to reschedule his testimony.